Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Back

Showing results (231-240 of 257) with videos related to

Pageof 26
Sort By:
AIDS Research and Human Retroviruses|June 25, 1999
Intracellular activation of 2',3'-dideoxyinosine and drug interactions in vitroS Kewn, P G Hoggard, J S Henry-Mowatt, et al.
Contraception|February 1, 1980
The pharmacokinetics of a large (3 mg) oral dose of ethynylestradiol in womenD J Back, H M Bolt, A M Breckenridge, et al.
Clinical Pharmacology and Therapeutics|October 1, 1978
Kinetics of norethindrone in women. I. Radioimmunoassay and concentrations during multiple dosingD J Back, A M Breckenridge, F E Crawford, et al.
Life Sciences|September 11, 1978
Biliary excretion of synthetic sex steroids in heterozygous and homozygous Gunn ratsD J Back, A M Breckenridge, F E Crawford, et al.
Contraception|March 1, 1981
The pharmacokinetics of levonorgestrel and ethynylestradiol in women - studies with Ovran and OvranetteD J Back, M Bates, A M Breckenridge, et al.
Contraception|August 1, 1978
Ethynylestradiol and norethindrone metabolism by everted sacs of rat ileumD J Back, M W Bates, A M Breckenridge, et al.
Contraception|March 1, 1982
The enzyme inducing effect of rifampicin in the rhesus monkey and its lack of interaction with oral contraceptive steroidsD J Back, J O Barkfeldt, A M Breckenridge, et al.
British Journal of Clinical Pharmacology|January 1, 1980
The effect of oral contraceptive steroids and enzyme inducing drugs on sex hormone binding globulin capacity in women [proceedings]D J Back, A M Breckenridge, F E Crawford, et al.
AIDS (London, England)|March 15, 1997
Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patientsC Merry, M G Barry, F Mulcahy, et al.
Clinical Pharmacology and Therapeutics|May 29, 2009
The relationships of ABCB1 3435C>T and CYP2B6 516G>T with high-density lipoprotein cholesterol in HIV-infected patients receiving EfavirenzT W Mahungu, D Nair, C J Smith, et al.
Pageof 26

Showing results (231-240 of 257) with videos related to

Sort By:
Pageof 26
AIDS Research and Human Retroviruses|June 25, 1999
Intracellular activation of 2',3'-dideoxyinosine and drug interactions in vitroS Kewn, P G Hoggard, J S Henry-Mowatt, et al.
Contraception|February 1, 1980
The pharmacokinetics of a large (3 mg) oral dose of ethynylestradiol in womenD J Back, H M Bolt, A M Breckenridge, et al.
Clinical Pharmacology and Therapeutics|October 1, 1978
Kinetics of norethindrone in women. I. Radioimmunoassay and concentrations during multiple dosingD J Back, A M Breckenridge, F E Crawford, et al.
Life Sciences|September 11, 1978
Biliary excretion of synthetic sex steroids in heterozygous and homozygous Gunn ratsD J Back, A M Breckenridge, F E Crawford, et al.
Contraception|March 1, 1981
The pharmacokinetics of levonorgestrel and ethynylestradiol in women - studies with Ovran and OvranetteD J Back, M Bates, A M Breckenridge, et al.
Contraception|August 1, 1978
Ethynylestradiol and norethindrone metabolism by everted sacs of rat ileumD J Back, M W Bates, A M Breckenridge, et al.
Contraception|March 1, 1982
The enzyme inducing effect of rifampicin in the rhesus monkey and its lack of interaction with oral contraceptive steroidsD J Back, J O Barkfeldt, A M Breckenridge, et al.
British Journal of Clinical Pharmacology|January 1, 1980
The effect of oral contraceptive steroids and enzyme inducing drugs on sex hormone binding globulin capacity in women [proceedings]D J Back, A M Breckenridge, F E Crawford, et al.
AIDS (London, England)|March 15, 1997
Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patientsC Merry, M G Barry, F Mulcahy, et al.
Clinical Pharmacology and Therapeutics|May 29, 2009
The relationships of ABCB1 3435C>T and CYP2B6 516G>T with high-density lipoprotein cholesterol in HIV-infected patients receiving EfavirenzT W Mahungu, D Nair, C J Smith, et al.
Pageof 26